Le Qin
Impact in
- Infectious Diseases top 2%
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
- Oncology top 5%
- CAR-T cell therapy research
- COVID-19 and healthcare impacts
Papers in
- Oncology 29
- CAR-T cell therapy research 15
-
- Radiation Dose and Imaging 11
- Cardiac Imaging and Diagnostics 7
- COVID-19 diagnosis using AI 6
- Co-authors
- Fuhua Yan (21 shared papers)Wenjie Yang (22 shared papers)Zenghui Cheng (6 shared papers)Qiqi Cao (6 shared papers)Qingfeng Sun (3 shared papers)Jianyi Dai (3 shared papers)Ashan Pan (3 shared papers)Peng Li (15 shared papers)
- Journals
- European Radiology (6 papers)Scientific Reports (3 papers)American Journal of Roentgenology (3 papers)BMC Cancer (3 papers)Frontiers in Immunology (2 papers)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Le Qin
94 papers receiving 2.3k citations
Hit Papers
Peers
Comparison fields: 5 of 149
- Infectious Diseases 789
- Oncology 735
- Radiology, Nuclear Medicine and Imaging 548
- Neurology 336
- Critical Care and Intensive Care Medicine 96
Countries citing papers authored by Le Qin
This map shows the geographic impact of Le Qin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Le Qin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Le Qin more than expected).
Fields of papers citing papers by Le Qin
This network shows the impact of papers produced by Le Qin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Le Qin. The network helps show where Le Qin may publish in the future.
Co-authors
The 25 scholars most cited alongside Le Qin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 103 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Clinical characteristics and imaging manifestations of the 2019 novel coronavirus disease (COVID-19):A multi-center study in Wenzhou city, Zhejiang, China Hit paper breakdown → | 2020 | 681 |
| 2 | 2017 | 221 | |
| 3 | 2020 | 219 | |
| 4 | 2017 | 106 | |
| 5 | 2017 | 79 | |
| 6 | 2017 | 78 | |
| 7 | 2020 | 51 | |
| 8 | 2009 | 46 | |
| 9 | 2022 | 42 | |
| 10 | 2021 | 37 | |
| 11 | 2020 | 35 | |
| 12 | 2016 | 31 | |
| 13 | 2020 | 30 | |
| 14 | 2021 | 29 | |
| 15 | 2020 | 29 | |
| 16 | 2019 | 29 | |
| 17 | 2020 | 29 | |
| 18 | 2020 | 26 | |
| 19 | 2023 | 26 | |
| 20 | 2018 | 23 |
About Le Qin
Le Qin is a scholar working on Oncology, Radiology, Nuclear Medicine and Imaging, Molecular Biology, Biomedical Engineering and Surgery, having authored 103 papers that have together received 2.4k indexed citations. Recurring topics across this work include CAR-T cell therapy research (15 papers), Advanced X-ray and CT Imaging (13 papers), Radiation Dose and Imaging (11 papers), Cardiac Imaging and Diagnostics (7 papers), Microbial Natural Products and Biosynthesis (7 papers), Virus-based gene therapy research (7 papers), Immunotherapy and Immune Responses (7 papers) and COVID-19 diagnosis using AI (6 papers). The work is most often cited by research in Infectious Diseases (789 citations), Oncology (735 citations), Radiology, Nuclear Medicine and Imaging (548 citations), Neurology (336 citations) and Critical Care and Intensive Care Medicine (96 citations). Le Qin has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Fuhua Yan, Wenjie Yang, Zenghui Cheng, Qiqi Cao, Qingfeng Sun, Jianyi Dai, Ashan Pan, Peng Li, Xiaoyang Wang and Jieming Qu. Their work appears in journals such as European Radiology, Scientific Reports, American Journal of Roentgenology, BMC Cancer and Frontiers in Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.